Revvity
Guillaume Baron currently serves as the Interim Managing Director at Revvity since September 2023. Prior to this role, Guillaume held the position of Global TB Product Manager at Oxford Immunotec from April 2022 to September 2023 and was previously employed at BD as the European Junior Product Manager for Blood Culture & TB and as the EMEA Demand & Supply Planner from May 2016 to March 2022. Additional experience includes working at Procter & Gamble as a Demand Planner & Key User from July 2014 to April 2016, and at Abercrombie & Fitch as Store Manager and Assistant Manager at the Champs-Elysees flagship store from July 2011 to June 2014. An academic background includes a Bachelor of Business Administration in Management and Marketing from the University of Mississippi, where Guillaume studied from August 2008 to May 2011.
This person is not in any teams
This person is not in any offices
Revvity
8 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com